|Drug Patent Number||Company||Drug Patent Title||Drug Patent Expiry||Activity Alert|
|These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.|
|US8829186||MEDICURE||Method for preparation of pitavastatin and pharmaceutical acceptable salts thereof|| |
(7 years from now)
Zypitamag is owned by Medicure.
Zypitamag contains Pitavastatin Magnesium.
Zypitamag has a total of 1 drug patent out of which 0 drug patents have expired.
Zypitamag was authorised for market use on 14 July, 2017.
Zypitamag is available in tablet;oral dosage forms.
The generics of Zypitamag are possible to be released after 19 January, 2031.
Market Authorisation Date: 14 July, 2017
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic